EP Biocomposites Past Earnings Performance
Past criteria checks 2/6
EP Biocomposites has been growing earnings at an average annual rate of 18.6%, while the Building industry saw earnings growing at 20.2% annually. Revenues have been declining at an average rate of 7.8% per year. EP Biocomposites's return on equity is 6.1%, and it has net margins of 6.5%.
Key information
18.6%
Earnings growth rate
-55.4%
EPS growth rate
| Building Industry Growth | 20.2% |
| Revenue growth rate | -7.8% |
| Return on equity | 6.1% |
| Net Margin | 6.5% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How EP Biocomposites makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 81 | 5 | 21 | 0 |
| 30 Jun 23 | 76 | 6 | 19 | 0 |
| 31 Mar 23 | 71 | 6 | 16 | 0 |
| 31 Dec 22 | 79 | 7 | 15 | 0 |
| 30 Sep 22 | 88 | 8 | 14 | 0 |
| 30 Jun 22 | 84 | 8 | 14 | 0 |
| 31 Mar 22 | 81 | 8 | 13 | 0 |
| 31 Mar 21 | 29 | 4 | 5 | 0 |
| 31 Mar 20 | 34 | 2 | 1 | 0 |
Quality Earnings: 543595 has high quality earnings.
Growing Profit Margin: 543595's current net profit margins (6.5%) are lower than last year (9.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543595's earnings have grown by 18.6% per year over the past 5 years.
Accelerating Growth: 543595's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 543595 had negative earnings growth (-38%) over the past year, making it difficult to compare to the Building industry average (34.2%).
Return on Equity
High ROE: 543595's Return on Equity (6.1%) is considered low.